1 study found for:    8568293 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)
Condition: HIV Infections
Intervention: Biological: rgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine

Indicates status has not been verified in more than two years